CD200 Protein (CD200) (AA 31-232) (Fc Tag)

N° du produit ABIN7274110

Détail du produit

Antigène: CD200

Type de proteíne: Recombinant

Attributs du protein: AA 31-232

Origine: Humain

Source: HEK-293 Cells

Purification/Conjugué: Cette CD200 protéine est marqué à la Fc Tag.

Fonction: Human CD200/OX-2 Protein

Séquence: Gln31-Gly232

Attributs du produit: Recombinant Human CD200/OX-2 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Gln31-Gly232.

Pureté: > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC

Stérilité: 0.22 μm filtered

niveau d'endotoxine: Less than 1EU per μg by the LAL method.

Biological Activity Comment: Immobilized Human CD200 R1, His Tag at 0.5μg/ml (100μl/Well) on the plate. Dose response curve for Human CD200, hFc Tag with the EC50 of 23.4ng/ml determined by ELISA. See testing image for detail.

Information d'application

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.

Buffer: Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: -20 to -80°C for 12 months as supplied from date of receipt., -80°C for 3-6 months after reconstitution., 2-8°C for 2-7 days after reconstitution., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Date de péremption: 12 months

Détail du antigène

Antigène: CD200

Autre désignation: CD200 (CD200 Produits)

Synonymes: MOX1 Protein, MOX2 Protein, MRC Protein, OX-2 Protein, CD200 Protein, Cspmo2 Protein, MRCOX2 Protein, Mox2 Protein, DKFZp459C0716 Protein, OX2 Protein, CD200 molecule Protein, Cd200 molecule Protein, CD200 antigen Protein, CD200 Protein, Cd200 Protein

Sujet: CD200 and its receptors are highly expressed in the lung, on epithelial cells and leukocytes, and emerging evidence links dysregulation of the CD200 pathway with asthma. Moreover, pharmacological modulation of CD200 receptors was shown to improve clinical and inflammatory outcomes of preclinical asthma models.

Poids moléculaire: 49.2 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Tris-Bis PAGE result.